HOME >> BIOLOGY >> NEWS
NIH awards $4.2 million grant to scientists at Scripps Research to speed DNA sequencing technologies

A team of scientists at The Scripps Research Institute in California and Oxford University in England have been awarded a $4.2 million five-year grant to conduct basic science aimed at speeding the rate at which the next generation of DNA sequencing technologies will become available to scientists and clinicians.

This award is part of a larger initiative announced today by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH). According to the NHGRI, the grants, which total $32 million, aim to advance the development of innovative sequencing technologies, reduce the cost of DNA sequencing, and expand the use of genomics in biomedical research and health care.

The new Scripps Research grant, titled "Single-Molecule DNA Sequencing with Engineered Nanopores," is a collaborative effort between the laboratories of Scripps Research Professor Reza Ghadiri, Ph.D., and Oxford Professor Hagan Bayley, Ph.D. The goal is to develop technology that enables scientists to sequence a single piece of DNA -- something that isn't yet possible.

Over the past decade, DNA sequencing costs have fallen more than 50-fold, fueled in large part by tools, technologies, and process improvements developed as part of the successful effort to sequence the human genome. However, it still costs about $10 million to sequence 3 billion base pairs the amount of DNA found in the genomes of humans and other mammals. Ultimately, NHGRI's vision is to cut the cost of whole-genome sequencing to $1,000 or less, which would enable the sequencing of individual genomes as part of routine medical care.

"Just as our fingerprints are unique, we have genetic fingerprints that are unique as well," says Ghadiri.

Ghadiri, Bayley, and their colleagues aim to engineer a device with the ability to recognize a nucleotide on the basis of changes in electrical current as it passes through a nanopore -- a naturally hollo
'"/>

Contact: Jason Bardi
jasonb@scripps.edu
858-784-9254
Scripps Research Institute
9-Aug-2005


Page: 1 2

Related biology news :

1. Argonne wins three R&D 100 awards for innovative technologies
2. ASBMB taps 8 scientists and 1 politician for top awards
3. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
4. US Department of Defense awards $1.6 million for implantable biochip research
5. 20 Kentucky firms share $1.9 million from state to match federal SBIR-STTR awards
6. The Cancer Genome Atlas awards funds for technology development
7. NIH awards nearly $21 million to fund cutting-edge research equipment
8. SNM presents awards on Capitol Hill
9. National awards for 2 University of York scientists
10. Burroughs Wellcome Fund awards $14M to support physician-scientists
11. NIH awards VBI, Mayo Clinic $2.4M to study chronic rhinosinusitis

Post Your Comments:
(Date:5/20/2013)... 2013) - A novel vaccine study from ... research that will be unveiled at the American Association ... meeting takes place Monday, May 20 - Wednesday, May ... , "The main goal of a vaccine is ... pathogen that causes the disease", explained Dr. Hemachand Tummala, ...
(Date:5/19/2013)... at the University of California, Davis have engineered a ... for light. They report their findings today at ... Microbiology. , "In this work, we used synthetic biology ... carbon dioxide and light energy for growth) cyanobacterial metabolism ... Jordan McEwen, the lead researcher on the study. ...
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
Breaking Biology News(10 mins):Germ-fighting vaccine system makes great strides in delivery 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... As the R&D sector becomes increasingly ... industry to deliver better products, faster. Collaborations between ... often means turning big ideas into reality, within ... with Sensidose AB and Recipharm, is one example ... market sooner. The partnership resulted in the development ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: